QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
QQQ   423.81 (-0.48%)
AAPL   167.08 (-0.55%)
MSFT   405.08 (-1.64%)
META   502.01 (+1.59%)
GOOGL   156.44 (+0.62%)
AMZN   179.38 (-1.05%)
TSLA   151.15 (-2.77%)
NVDA   845.77 (+0.64%)
AMD   154.58 (+0.36%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.01 (-0.25%)
MU   112.49 (-3.30%)
GE   153.69 (-1.27%)
CGC   8.08 (+24.50%)
DIS   112.96 (+0.02%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.22 (-1.64%)
XOM   118.38 (-0.21%)
NYSE:ITGR

Integer (ITGR) Stock Price, News & Analysis

$117.59
-0.93 (-0.78%)
(As of 03:21 PM ET)
Today's Range
$117.54
$119.63
50-Day Range
$98.56
$119.31
52-Week Range
$69.40
$121.53
Volume
204,124 shs
Average Volume
309,825 shs
Market Capitalization
$3.94 billion
P/E Ratio
43.71
Dividend Yield
N/A
Price Target
$120.50

Integer MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
1.7% Upside
$120.50 Price Target
Short Interest
Bearish
7.39% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Integer in the last 14 days
Based on 14 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
15.85%
From $5.30 to $6.14 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.43 out of 5 stars

Medical Sector

713th out of 914 stocks

Electromedical Equipment Industry

13th out of 20 stocks

ITGR stock logo

About Integer Stock (NYSE:ITGR)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

ITGR Stock Price History

ITGR Stock News Headlines

Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Integer (ITGR) Scheduled to Post Earnings on Thursday
Integer (NYSE:ITGR) Reaches New 12-Month High at $119.51
Integer (NYSE:ITGR) Upgraded to Buy by Bank of America
Nvidia Has a BIG Problem — Here’s Who Benefits MOST
#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'
Integer (NYSE:ITGR) Given New $139.00 Price Target at KeyCorp
The Latest Analyst Ratings For Integer Holdings
KeyBanc Keeps Their Buy Rating on Integer Holdings (ITGR)
ITGR Aug 2024 110.000 call
ITGR May 2024 90.000 call
Integer Holdings Corp
See More Headlines
Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/15/2024
Today
4/18/2024
Next Earnings (Confirmed)
4/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Previous Symbol
NASDAQ:ITGR
CUSIP
39153L10
Employees
10,500
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$120.50
High Stock Price Target
$139.00
Low Stock Price Target
$88.00
Potential Upside/Downside
+2.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

Net Income
$90.65 million
Pretax Margin
6.72%

Debt

Sales & Book Value

Annual Sales
$1.60 billion
Cash Flow
$7.86 per share
Book Value
$45.58 per share

Miscellaneous

Free Float
32,888,000
Market Cap
$3.95 billion
Optionable
Optionable
Beta
1.10
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Joseph W. DziedzicMr. Joseph W. Dziedzic (Age 56)
    President, CEO & Director
    Comp: $2M
  • Mr. Payman Khales (Age 54)
    President of Cardio & Vascular
    Comp: $652.92k
  • Mr. Diron Smith (Age 50)
    Executive VP & CFO
  • Mr. John Harris (Age 64)
    Executive Vice President of Global Operations & Manufacturing Strategy
    Comp: $521.18k
  • Mr. Tom P. Thomas (Age 53)
    VP, Corporate Controller & Principal Accounting Officer
  • Mr. Andrew Senn (Age 42)
    Senior Vice President of Strategy, Business Development & Investor Relations
  • Mr. McAlister C. Marshall II (Age 54)
    Senior VP, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary
  • Mr. Kirk K. Thor (Age 60)
    Executive VP & Chief Human Resources Officer
    Comp: $689.95k
  • Ms. Margaret Carthy (Age 60)
    Executive VP of Global Quality & Regulatory Affairs
  • Mr. Jim Stephens (Age 50)
    President of Cardiac Rhythm Management & Neuromodulation

ITGR Stock Analysis - Frequently Asked Questions

Should I buy or sell Integer stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings
or view top-rated stocks.

What is Integer's stock price target for 2024?

6 Wall Street analysts have issued 1 year price objectives for Integer's stock. Their ITGR share price targets range from $88.00 to $139.00. On average, they anticipate the company's share price to reach $120.50 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price.
View analysts price targets for ITGR
or view top-rated stocks among Wall Street analysts.

How have ITGR shares performed in 2024?

Integer's stock was trading at $99.08 at the beginning of the year. Since then, ITGR stock has increased by 19.6% and is now trading at $118.53.
View the best growth stocks for 2024 here
.

When is Integer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our ITGR earnings forecast
.

How can I listen to Integer's earnings call?

Integer will be holding an earnings conference call on Thursday, April 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 609-800-9909 with passcode "9252310".

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) announced its quarterly earnings results on Thursday, February, 15th. The medical equipment provider reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.05. The medical equipment provider had revenue of $413.15 million for the quarter, compared to analysts' expectations of $409.04 million. Integer had a trailing twelve-month return on equity of 10.80% and a net margin of 5.68%. Integer's revenue was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.11 earnings per share.

What guidance has Integer issued on next quarter's earnings?

Integer issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided EPS guidance of 5.010-5.430 for the period, compared to the consensus earnings per share estimate of 5.450. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Who are Integer's major shareholders?

Integer's stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (1.36%), Park Avenue Securities LLC (0.02%), Guidance Capital Inc. (0.01%) and Canandaigua National Bank & Trust Co. (0.01%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Donald J Spence, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends
.

How do I buy shares of Integer?

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:ITGR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners